DGX实时信号 | 通过Getagraph.com最大化利润

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

Stats
今日成交量	579 272
平均成交量	1.05M
市值	14.92B
EPS	$0 ( 2024-04-25 )
下一个收益日期	( $2.32 ) 2024-07-24
Last Dividend	$0.750 ( 2024-04-05 )
Next Dividend	$0 ( N/A )
P/E	18.09
ATR14	$0.0790 (0.06%)

Insider Trading

Date	Person	Action	Amount	type
2024-04-22	Gregg Vicky B	Buy	81	Common Stock
2024-04-22	Kuppusamy Karthik	Buy	45	Common Stock
2024-04-22	Plewman Patrick	Buy	69	Common Stock
2024-04-22	Samad Sam	Buy	24	Common Stock
2024-04-01	Ring Timothy M	Buy	311	Phantom Stock Units

INSIDER POWER
70.91
Last 98 transactions
Buy: 293 398 \| Sell: 50 988

音量相关性

長: -0.35 (neutral)

短: -0.80 (moderate negative)

Signal:(42.582) Neutral

Quest Diagnostics Inc 相关性

10 最正相关
LLY	0.865
PCK	0.863
PFE	0.858
JNJ	0.856
MOH	0.848
CHAD	0.846
XLV	0.841
CLII	0.839
ADM	0.837
EVTL	0.835

10 最负相关
YSAC	-0.949
MTW	-0.895
MNSO	-0.887
BH	-0.878
STLA	-0.877
STN	-0.874
RDW	-0.871
NOA	-0.867
NGL-PC	-0.862
NGL-PB	-0.859

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Quest Diagnostics Inc 相关性 - 货币/商品

0.07
( neutral )

0.00
( neutral )

-0.59
( weak negative )

0.01
( neutral )

0.23
( neutral )

Quest Diagnostics Inc 财务报表

Annual	2023
营收:	$9.25B
毛利润:	$2.96B (32.00 %)
EPS:	$7.59

FY	2023
营收:	$9.25B
毛利润:	$2.96B (32.00 %)
EPS:	$7.59

FY	2022
营收:	$9.88B
毛利润:	$3.43B (34.74 %)
EPS:	$8.12

FY	2021
营收:	$10.79B
毛利润:	$4.21B (39.02 %)
EPS:	$16.91

Financial Reports:

No articles found.

Quest Diagnostics Inc Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.660 (N/A)	$0.660 (N/A)	$0.660 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.710 (N/A)	$0.750 (N/A)	$0 (N/A)	$0 (N/A)

Quest Diagnostics Inc Dividend Information - Dividend King

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.66 - Increase likely (53.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$0.0750	2004-01-06
Last Dividend	$0.750	2024-04-05
Next Dividend	$0	N/A
Payout Date	2024-04-22
Next Payout Date	N/A
# dividends	82	--
Total Paid Out	$26.61	--
Avg. Dividend % Per Year	1.55%	--
Score	5.89	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	7.66
Div. Directional Score	9.84	--

Next Divdend (Est)
(2024-07-10)

$0.762 Estimate 73.83 %

Dividend Stability

0.98 Excellent

Dividend Score

5.89

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2004	$0.300	0.83%
2005	$0.345	0.73%
2006	$0.390	0.76%
2007	$0.400	0.78%
2008	$0.400	0.77%
2009	$0.400	0.76%
2010	$0.400	0.65%
2011	$0.400	0.73%
2012	$0.680	1.18%
2013	$1.200	2.05%
2014	$1.290	2.44%
2015	$1.470	2.13%
2016	$1.580	2.23%
2017	$1.800	1.95%
2018	$1.950	1.97%
2019	$2.12	2.58%
2020	$2.21	2.09%
2021	$2.42	2.00%
2022	$2.60	1.58%
2023	$2.79	1.79%
2024	$1.460	1.04%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0911	1.500	8.18	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0606	1.200	7.98	9.57	[0 - 0.3]
returnOnEquityTTM	0.133	1.500	9.63	10.00	[0.1 - 1]
payoutRatioTTM	0.377	-1.000	6.23	-6.23	[0 - 1]
currentRatioTTM	0.970	0.800	-0.152	-0.122	[1 - 3]
quickRatioTTM	0.782	0.800	-0.109	-0.0868	[0.8 - 2.5]
cashRatioTTM	0.206	1.500	9.97	10.00	[0.2 - 2]
debtRatioTTM	0.349	-1.500	4.19	-6.29	[0 - 0.6]
interestCoverageTTM	7.95	1.000	8.17	8.17	[3 - 30]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	8.53	2.00	5.73	10.00	[0 - 20]
debtEquityRatioTTM	0.756	-1.500	6.98	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.327	1.000	7.88	7.88	[0.2 - 0.8]
operatingProfitMarginTTM	0.142	1.000	9.16	9.16	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.274	1.000	9.59	9.59	[0.2 - 2]
assetTurnoverTTM	0.666	0.800	8.90	7.12	[0.5 - 2]
Total Score				12.03

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	17.62	1.000	8.32	0	[1 - 100]
returnOnEquityTTM	0.133	2.50	9.76	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	8.53	2.00	7.16	10.00	[0 - 30]
dividendYielPercentageTTM	2.15	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	12.00	2.00	6.00	10.00	[0 - 30]
payoutRatioTTM	0.377	1.500	6.23	-6.23	[0 - 1]
pegRatioTTM	0.619	1.500	9.21	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.143	1.000	8.91	0	[0.1 - 0.5]
Total Score				7.66

Quest Diagnostics Inc

Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.